chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site swelling
Clinical narrative: swelling at injection site; stomach ache; fever; Felt severe fatigue; flu like symptoms; diarrhea; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (flu like symptoms), DIARRHOEA (diarrhea), ABDOMINAL PAIN UPPER (stomach ache), PYREXIA (fever) and FATIGUE (Felt severe fatigue) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013M20A and 032L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Irritable bowel syndrome.   On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 19-Feb-2021, the patient experienced INFLUENZA LIKE ILLNESS (flu like symptoms), DIARRHOEA (diarrhea), PYREXIA (fever) and FATIGUE (Felt severe fatigue). On 21-Feb-2021, the patient experienced ABDOMINAL PAIN UPPER (stomach ache). On 22-Feb-2021, the patient experienced VACCINATION SITE SWELLING (swelling at injection site). At the time of the report, INFLUENZA LIKE ILLNESS (flu like symptoms), DIARRHOEA (diarrhea), ABDOMINAL PAIN UPPER (stomach ache), PYREXIA (fever), FATIGUE (Felt severe fatigue) and VACCINATION SITE SWELLING (swelling at injection site) had not resolved.            The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) was not applicable.  No concomitant medications reported by investigator o No treatment medications provided by the reporter.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site mass, Vaccination site erythema
Clinical narrative: injection site mass; red, round 2x2 inch; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (red, round 2x2 inch) and INJECTION SITE MASS (injection site mass) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 042L20A and 012A21A) for COVID-19 vaccination.     Concomitant products included ATORVASTATIN and LOSARTAN for an unknown indication.   On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1. On 24-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to at an unspecified dose. On 22-Jan-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced VACCINATION SITE ERYTHEMA (red, round 2x2 inch). On 24-Feb-2021, the patient experienced INJECTION SITE MASS (injection site mass). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form. At the time of the report, VACCINATION SITE ERYTHEMA (red, round 2x2 inch) and INJECTION SITE MASS (injection site mass) outcome was unknown. Not Provided          This case was linked to US-MODERNATX, INC.-MOD-2021-051545 (Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-051545:Companion case
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Bedridden, Decreased appetite, Fatigue, Feeling abnormal, Malaise
Clinical narrative: body aches; Felt tired; Fever; Head felt funny/weird; Did not have appetite; Slept around 11-12 hours; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL, DECREASED APPETITE, BEDRIDDEN, MALAISE, and FATIGUE in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030L20A and 031L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No relevant history was provided by the reporter.  Concomitant products included LOSARTAN POTASSIUM for Blood pressure management, OMEPRAZOLE, ASPIRIN 81, and VITAMIN D3 for an unknown indication.   On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 18-Feb-2021, the patient experienced FEELING ABNORMAL, DECREASED APPETITE, BEDRIDDEN, FATIGUE, and PYREXIA. On 19-Feb-2021, the patient experienced MALAISE. The patient was treated with TYLENOL at an unspecified dose and frequency. On 20-Feb-2021, FEELING ABNORMAL, DECREASED APPETITE, BEDRIDDEN, MALAISE, FATIGUE, and PYREXIA had resolved.            This case was linked to US-MODERNATX, INC.-MOD-2021-051576. This case was linked to MOD-2021-051576.   Most recent FOLLOW-UP information incorporated above includes: On 10-May-2021: Non-significant follow-up: Consumer informed that she will be mailing the ADR form to the address indicated on the first request.    US-MODERNATX, INC MOD-2021-051576: first dose
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: body aches; Felt tired; Fever; Head felt funny/weird; Did not have appetite; Slept around 11-12 hours; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL, DECREASED APPETITE, BEDRIDDEN, MALAISE, and FATIGUE in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030L20A and 031L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No relevant history was provided by the reporter.  Concomitant products included LOSARTAN POTASSIUM for Blood pressure management, OMEPRAZOLE, ASPIRIN 81, and VITAMIN D3 for an unknown indication.   On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 18-Feb-2021, the patient experienced FEELING ABNORMAL, DECREASED APPETITE, BEDRIDDEN, FATIGUE, and PYREXIA. On 19-Feb-2021, the patient experienced MALAISE. The patient was treated with TYLENOL at an unspecified dose and frequency. On 20-Feb-2021, FEELING ABNORMAL, DECREASED APPETITE, BEDRIDDEN, MALAISE, FATIGUE, and PYREXIA had resolved.            This case was linked to US-MODERNATX, INC.-MOD-2021-051576. This case was linked to MOD-2021-051576.   Most recent FOLLOW-UP information incorporated above includes: On 10-May-2021: Non-significant follow-up: Consumer informed that she will be mailing the ADR form to the address indicated on the first request.    US-MODERNATX, INC MOD-2021-051576: first dose
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration, Vaccination site pain
Clinical narrative: invalid dose (over 42 days period); Arm Soreness; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (invalid dose (over 42 days period)) and PAIN IN EXTREMITY (Arm Soreness) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for an unknown indication.     Concurrent medical conditions included Diabetes and Hypertension. Concomitant products included METFORMIN, METOPROLOL, LISINOPRIL, DABIGATRAN ETEXILATE MESILATE (PRADAXA) and FLECAINIDE.    On 20-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Mar-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (invalid dose (over 42 days period)) and PAIN IN EXTREMITY (Arm Soreness). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (invalid dose (over 42 days period)) and PAIN IN EXTREMITY (Arm Soreness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       In addition, patient shared that she have underlying diseases such as A. Fib, DM, Mini stroke, a mass in the left lower lung and an ablation procedure in the heart.   Reporter did not allow further contact; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Hyperhidrosis, Myalgia, Pyrexia
Clinical narrative: sweating; fever; chills; body aches and states " of course is extremely sore; This spontaneous case was reported by a consumer and describes the occurrence of HYPERHIDROSIS (sweating), PYREXIA (fever), CHILLS (chills) and MYALGIA (body aches and states " of course is extremely sore) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Mar-2021, the patient experienced HYPERHIDROSIS (sweating), PYREXIA (fever), CHILLS (chills) and MYALGIA (body aches and states " of course is extremely sore). At the time of the report, HYPERHIDROSIS (sweating), PYREXIA (fever), CHILLS (chills) and MYALGIA (body aches and states " of course is extremely sore) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication provided. No treatment medication provided.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Heart rate, Myalgia, Nausea
Clinical narrative: Heart rate 120-130; vomiting sensation; chills; nausea; bad headache; body aches; fever; This spontaneous case was reported by a consumer and describes the occurrence of TACHYCARDIA (Heart rate 120-130), VOMITING (vomiting sensation), CHILLS (chills), NAUSEA (nausea) and HEADACHE (bad headache) in a 35-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 18-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Mar-2021, the patient experienced TACHYCARDIA (Heart rate 120-130), VOMITING (vomiting sensation), CHILLS (chills), NAUSEA (nausea), HEADACHE (bad headache), MYALGIA (body aches) and PYREXIA (fever). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, TACHYCARDIA (Heart rate 120-130), VOMITING (vomiting sensation), CHILLS (chills), NAUSEA (nausea), HEADACHE (bad headache), MYALGIA (body aches) and PYREXIA (fever) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 19-Mar-2021, Heart rate: 120-130.         The action taken with mRNA-1273 in response to the event was not applicable. No concomitant medication reported.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Tachycardia, Vomiting
Clinical narrative: Heart rate 120-130; vomiting sensation; chills; nausea; bad headache; body aches; fever; This spontaneous case was reported by a consumer and describes the occurrence of TACHYCARDIA (Heart rate 120-130), VOMITING (vomiting sensation), CHILLS (chills), NAUSEA (nausea) and HEADACHE (bad headache) in a 35-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 18-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Mar-2021, the patient experienced TACHYCARDIA (Heart rate 120-130), VOMITING (vomiting sensation), CHILLS (chills), NAUSEA (nausea), HEADACHE (bad headache), MYALGIA (body aches) and PYREXIA (fever). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, TACHYCARDIA (Heart rate 120-130), VOMITING (vomiting sensation), CHILLS (chills), NAUSEA (nausea), HEADACHE (bad headache), MYALGIA (body aches) and PYREXIA (fever) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 19-Mar-2021, Heart rate: 120-130.         The action taken with mRNA-1273 in response to the event was not applicable. No concomitant medication reported.
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Maternal exposure during pregnancy, Pain in extremity, Vaccination site pruritus, Vaccination site swelling
Clinical narrative: itchy; injection site became swollen; red; arm was a little sore; Maternal exposure during pregnancy; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm was a little sore), MATERNAL EXPOSURE DURING PREGNANCY (Maternal exposure during pregnancy), VACCINATION SITE PRURITUS (itchy), VACCINATION SITE SWELLING (injection site became swollen) and INJECTION SITE ERYTHEMA (red) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.  No Medical History information was reported.    On 09-Mar-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. Last menstrual period and estimated date of delivery were not provided. On 09-Mar-2021, the patient experienced PAIN IN EXTREMITY (arm was a little sore) and MATERNAL EXPOSURE DURING PREGNANCY (Maternal exposure during pregnancy). On 18-Mar-2021, the patient experienced VACCINATION SITE PRURITUS (itchy), VACCINATION SITE SWELLING (injection site became swollen) and INJECTION SITE ERYTHEMA (red). On 09-Mar-2021, MATERNAL EXPOSURE DURING PREGNANCY (Maternal exposure during pregnancy) had resolved. On 11-Mar-2021, PAIN IN EXTREMITY (arm was a little sore) had resolved. At the time of the report, VACCINATION SITE PRURITUS (itchy), VACCINATION SITE SWELLING (injection site became swollen) and INJECTION SITE ERYTHEMA (red) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was not reported. No treatment medication was reported
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Headache, Myalgia, Nausea
Clinical narrative: nausea; vomiting; chills; headache; muscle aches; Pyrexia; This spontaneous case was reported by a consumer and describes the occurrence of NAUSEA (nausea), VOMITING (vomiting), CHILLS (chills), HEADACHE (headache) and MYALGIA (muscle aches) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 045A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Mar-2021, the patient experienced NAUSEA (nausea), VOMITING (vomiting), CHILLS (chills), HEADACHE (headache), MYALGIA (muscle aches) and PYREXIA (Pyrexia). At the time of the report, NAUSEA (nausea), VOMITING (vomiting), CHILLS (chills), HEADACHE (headache), MYALGIA (muscle aches) and PYREXIA (Pyrexia) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 18-Mar-2021, Body temperature: 100.2 (High) 100.2 fahrenheit.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Medications: medicines for diabetes and blood pressure.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Vomiting
Clinical narrative: nausea; vomiting; chills; headache; muscle aches; Pyrexia; This spontaneous case was reported by a consumer and describes the occurrence of NAUSEA (nausea), VOMITING (vomiting), CHILLS (chills), HEADACHE (headache) and MYALGIA (muscle aches) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 045A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Mar-2021, the patient experienced NAUSEA (nausea), VOMITING (vomiting), CHILLS (chills), HEADACHE (headache), MYALGIA (muscle aches) and PYREXIA (Pyrexia). At the time of the report, NAUSEA (nausea), VOMITING (vomiting), CHILLS (chills), HEADACHE (headache), MYALGIA (muscle aches) and PYREXIA (Pyrexia) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 18-Mar-2021, Body temperature: 100.2 (High) 100.2 fahrenheit.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Medications: medicines for diabetes and blood pressure.
Age: 20.0
Sex: F
Vaccine: COVID19
Symptoms: Illness, Vomiting
Clinical narrative: Looked sick; Vomiting/Threw up; This spontaneous case was reported by a consumer and describes the occurrence of VOMITING (Vomiting/Threw up) and ILLNESS (Looked sick) in a 20-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002B21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included PROPRANOLOL HYDROCHLORIDE (PROPANOLOL BOEHRINGER), ESCITALOPRAM OXALATE (LEXAPRO), TRAZODONE, Risperidal and MELATONIN for an unknown indication.    On 13-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Mar-2021, the patient experienced VOMITING (Vomiting/Threw up). On 19-Mar-2021, the patient experienced ILLNESS (Looked sick). At the time of the report, VOMITING (Vomiting/Threw up) and ILLNESS (Looked sick) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No laboratory details were  provided.  Treatment medications included Benadryl and Zofran.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Tremor
Clinical narrative: Shakings; Chills; This spontaneous case was reported by a consumer and describes the occurrence of TREMOR (Shakings) and CHILLS (Chills) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Mar-2021, the patient experienced TREMOR (Shakings) and CHILLS (Chills). At the time of the report, TREMOR (Shakings) and CHILLS (Chills) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant medications was reported No treatment information was provided   Most recent FOLLOW-UP information incorporated above includes: On 24-Jul-2021: Event outcome updated. to resolved.
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: Headache; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache) in a 64-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 022M20A and 042L20A) for COVID-19 vaccination.     No medical history was reported.  Concomitant products included ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) and FENTANYL for an unknown indication.   On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 18-Feb-2021, the patient experienced HEADACHE (Headache). At the time of the report, HEADACHE (Headache) outcome was unknown.            Treatment information is not provided.  Action taken with mRNA-1273 in response to the event was not applicable.   This case was linked to MOD-2021-016430 (Patient Link).
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Haematuria
Clinical narrative: My urine is bloody; This spontaneous case was reported by a consumer and describes the occurrence of HAEMATURIA (My urine is bloody) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011A21A and 023M20A) for COVID-19 vaccination.     Concomitant products included ROSUVASTATIN for an unknown indication.   On 12-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to at an unspecified dose. On 19-Mar-2021, the patient experienced HAEMATURIA (My urine is bloody). At the time of the report, HAEMATURIA (My urine is bloody) outcome was unknown. Not Provided          No laboratory details were  provided.  No treatment medications were reported.  Action taken with mRNA-1273 in response to the events was not applicable.
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: Tested positive for COVID-19; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Tested positive for COVID-19) in an 80-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 02SA21A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In March 2021, the patient experienced COVID-19 (Tested positive for COVID-19). At the time of the report, COVID-19 (Tested positive for COVID-19) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In March 2021, COVID-19: Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medications were provided No Treatment information provided
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, Arthralgia, Chills, Decreased appetite, Fatigue
Clinical narrative: upset stomach; no apatite; felt terrible; swelling at the site of injection; headache; joint pain; chills; muscle pain; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL DISCOMFORT (upset stomach), DECREASED APPETITE (no apatite), MALAISE (felt terrible), VACCINATION SITE SWELLING (swelling at the site of injection) and HEADACHE (headache) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.    On 19-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Mar-2021, the patient experienced ABDOMINAL DISCOMFORT (upset stomach), DECREASED APPETITE (no apatite), MALAISE (felt terrible), VACCINATION SITE SWELLING (swelling at the site of injection), HEADACHE (headache), ARTHRALGIA (joint pain), CHILLS (chills), MYALGIA (muscle pain) and FATIGUE (fatigue). At the time of the report, ABDOMINAL DISCOMFORT (upset stomach), DECREASED APPETITE (no apatite), MALAISE (felt terrible), VACCINATION SITE SWELLING (swelling at the site of injection), HEADACHE (headache), ARTHRALGIA (joint pain), CHILLS (chills), MYALGIA (muscle pain) and FATIGUE (fatigue) outcome was unknown.            No concomitant medication was reported , No treatment medication was reported . Follow-up received on 09-May-2021 included no new information   This case was linked to MOD-2021-051629 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 09-May-2021: TCR received on 9-may-2021, NNI was updated .
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Malaise, Myalgia, Vaccination site swelling
Clinical narrative: upset stomach; no apatite; felt terrible; swelling at the site of injection; headache; joint pain; chills; muscle pain; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL DISCOMFORT (upset stomach), DECREASED APPETITE (no apatite), MALAISE (felt terrible), VACCINATION SITE SWELLING (swelling at the site of injection) and HEADACHE (headache) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.    On 19-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Mar-2021, the patient experienced ABDOMINAL DISCOMFORT (upset stomach), DECREASED APPETITE (no apatite), MALAISE (felt terrible), VACCINATION SITE SWELLING (swelling at the site of injection), HEADACHE (headache), ARTHRALGIA (joint pain), CHILLS (chills), MYALGIA (muscle pain) and FATIGUE (fatigue). At the time of the report, ABDOMINAL DISCOMFORT (upset stomach), DECREASED APPETITE (no apatite), MALAISE (felt terrible), VACCINATION SITE SWELLING (swelling at the site of injection), HEADACHE (headache), ARTHRALGIA (joint pain), CHILLS (chills), MYALGIA (muscle pain) and FATIGUE (fatigue) outcome was unknown.            No concomitant medication was reported , No treatment medication was reported . Follow-up received on 09-May-2021 included no new information   This case was linked to MOD-2021-051629 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 09-May-2021: TCR received on 9-may-2021, NNI was updated .
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Chills, Fatigue, Headache, Pain in extremity
Clinical narrative: had a really sore arm; a bad headache; upper back hurt; chills to where she kept being cold and shivery even when she had the heat on; tired; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (had a really sore arm), HEADACHE (a bad headache), BACK PAIN (upper back hurt), CHILLS (chills to where she kept being cold and shivery even when she had the heat on) and FATIGUE (tired) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included METOPROLOL SUCCINATE and ATORVASTATIN for an unknown indication.   On 23-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 20-Feb-2021, the patient experienced PAIN IN EXTREMITY (had a really sore arm), HEADACHE (a bad headache), BACK PAIN (upper back hurt), CHILLS (chills to where she kept being cold and shivery even when she had the heat on) and FATIGUE (tired). At the time of the report, PAIN IN EXTREMITY (had a really sore arm), HEADACHE (a bad headache), BACK PAIN (upper back hurt), CHILLS (chills to where she kept being cold and shivery even when she had the heat on) and FATIGUE (tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       No treatment information was provided.
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: Eye pain, Vaccination site pain, Vision blurred
Clinical narrative: he has been having blurry vision; soreness in the right eye.; experienced pain and soreness in the arm where he received the vaccine; This spontaneous case was reported by a consumer and describes the occurrence of VISION BLURRED (he has been having blurry vision), EYE PAIN (soreness in the right eye.) and VACCINATION SITE PAIN (experienced pain and soreness in the arm where he received the vaccine) in a 53-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2021, the patient experienced VISION BLURRED (he has been having blurry vision), EYE PAIN (soreness in the right eye.) and VACCINATION SITE PAIN (experienced pain and soreness in the arm where he received the vaccine). At the time of the report, VISION BLURRED (he has been having blurry vision), EYE PAIN (soreness in the right eye.) and VACCINATION SITE PAIN (experienced pain and soreness in the arm where he received the vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  No laboratory details were  provided.  No treatment medications were reported.
Age: 90.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Pyrexia, Rash
Clinical narrative: Big rash over shoulder extending to left elbow/Rash over left arm; fever 99.3; headache; This spontaneous case was reported by a consumer and describes the occurrence of RASH (Big rash over shoulder extending to left elbow/Rash over left arm), PYREXIA (fever 99.3) and HEADACHE (headache) in a 90-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included ACETYLSALICYLIC ACID (ASPIRIN 81) for an unknown indication.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Mar-2021, the patient experienced RASH (Big rash over shoulder extending to left elbow/Rash over left arm), PYREXIA (fever 99.3) and HEADACHE (headache). At the time of the report, RASH (Big rash over shoulder extending to left elbow/Rash over left arm), PYREXIA (fever 99.3) and HEADACHE (headache) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       she experienced rash on Left shoulder, left arm and up to left elbow. 2 days later 16 march she developed big rash 10 inch by 10 inch on left shoulder and left arm with fever 99.3 and headache, she consulted her HCP. She is using anti hist lotion for that. She take aspirin and thyroid medicine as concomitant medication.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Body temperature, Myalgia, Pain, Pyrexia
Clinical narrative: Joint pain; Fever between 99.8 and 100.2; Injection site warm to touch; Pain; Muscle aches; Sore injection site; A little swollen injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Injection site warm to touch), PAIN (Pain), MYALGIA (Muscle aches), VACCINATION SITE PAIN (Sore injection site) and VACCINATION SITE SWELLING (A little swollen injection site) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 045A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Mar-2021, the patient experienced VACCINATION SITE WARMTH (Injection site warm to touch), PAIN (Pain), MYALGIA (Muscle aches), VACCINATION SITE PAIN (Sore injection site) and VACCINATION SITE SWELLING (A little swollen injection site). On 19-Mar-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced PYREXIA (Fever between 99.8 and 100.2). On an unknown date, the patient experienced ARTHRALGIA (Joint pain). At the time of the report, VACCINATION SITE WARMTH (Injection site warm to touch), PAIN (Pain), MYALGIA (Muscle aches), VACCINATION SITE PAIN (Sore injection site), VACCINATION SITE SWELLING (A little swollen injection site), PYREXIA (Fever between 99.8 and 100.2) and ARTHRALGIA (Joint pain) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 19-Mar-2021, Body temperature: 100.2 °F (High) Initial temperature was 99.8 and latest temperature is 100.2.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant products included blood pressure medications.  Treatment for the first dose events were not reported.   Most recent FOLLOW-UP information incorporated above includes: On 16-Apr-2021: follow-up document received on 17-APR-2021.The product details and concomitant medication was updated. The event joint pain was added. On 04-Aug-2021: Follow-up 1 received on 05-AUG-2021.Event outcome updated
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site pain, Vaccination site swelling, Vaccination site warmth
Clinical narrative: Joint pain; Fever between 99.8 and 100.2; Injection site warm to touch; Pain; Muscle aches; Sore injection site; A little swollen injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Injection site warm to touch), PAIN (Pain), MYALGIA (Muscle aches), VACCINATION SITE PAIN (Sore injection site) and VACCINATION SITE SWELLING (A little swollen injection site) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 045A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Mar-2021, the patient experienced VACCINATION SITE WARMTH (Injection site warm to touch), PAIN (Pain), MYALGIA (Muscle aches), VACCINATION SITE PAIN (Sore injection site) and VACCINATION SITE SWELLING (A little swollen injection site). On 19-Mar-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced PYREXIA (Fever between 99.8 and 100.2). On an unknown date, the patient experienced ARTHRALGIA (Joint pain). At the time of the report, VACCINATION SITE WARMTH (Injection site warm to touch), PAIN (Pain), MYALGIA (Muscle aches), VACCINATION SITE PAIN (Sore injection site), VACCINATION SITE SWELLING (A little swollen injection site), PYREXIA (Fever between 99.8 and 100.2) and ARTHRALGIA (Joint pain) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 19-Mar-2021, Body temperature: 100.2 °F (High) Initial temperature was 99.8 and latest temperature is 100.2.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant products included blood pressure medications.  Treatment for the first dose events were not reported.   Most recent FOLLOW-UP information incorporated above includes: On 16-Apr-2021: follow-up document received on 17-APR-2021.The product details and concomitant medication was updated. The event joint pain was added. On 04-Aug-2021: Follow-up 1 received on 05-AUG-2021.Event outcome updated
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Pain, Pain in extremity, Pruritus
Clinical narrative: sore arm; Had itching in the past, resolved and after vaccine itching started again, all over body; Achiness, headaches, sore arm; Achiness, headaches, sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Achiness, headaches, sore arm), PAIN IN EXTREMITY (sore arm), PRURITUS (Had itching in the past, resolved and after vaccine itching started again, all over body) and HEADACHE (Achiness, headaches, sore arm) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included FISH OIL, POTASSIUM, VITAMIN D3, ELDERBERRY [SAMBUCUS NIGRA] and FEXOFENADINE HYDROCHLORIDE (ALLEGRA) for an unknown indication.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Mar-2021, the patient experienced PAIN (Achiness, headaches, sore arm). On an unknown date, the patient experienced PAIN IN EXTREMITY (sore arm), PRURITUS (Had itching in the past, resolved and after vaccine itching started again, all over body) and HEADACHE (Achiness, headaches, sore arm). At the time of the report, PAIN (Achiness, headaches, sore arm), PAIN IN EXTREMITY (sore arm), PRURITUS (Had itching in the past, resolved and after vaccine itching started again, all over body) and HEADACHE (Achiness, headaches, sore arm) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, Feeling cold, Headache, Limb discomfort, Neck pain
Clinical narrative: Sensitivity in her arm; Headache in forehead and back of neck; Little bit of chilling; Stomach felt upset; Headache in forehead and back of neck; This spontaneous case was reported by a consumer and describes the occurrence of LIMB DISCOMFORT (Sensitivity in her arm), NECK PAIN (Headache in forehead and back of neck), FEELING COLD (Little bit of chilling), ABDOMINAL DISCOMFORT (Stomach felt upset) and HEADACHE (Headache in forehead and back of neck) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, the patient experienced LIMB DISCOMFORT (Sensitivity in her arm), NECK PAIN (Headache in forehead and back of neck), FEELING COLD (Little bit of chilling), ABDOMINAL DISCOMFORT (Stomach felt upset) and HEADACHE (Headache in forehead and back of neck). At the time of the report, LIMB DISCOMFORT (Sensitivity in her arm), NECK PAIN (Headache in forehead and back of neck), FEELING COLD (Little bit of chilling), ABDOMINAL DISCOMFORT (Stomach felt upset) and HEADACHE (Headache in forehead and back of neck) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were provided.  No treatment information was provided.
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Exposure during pregnancy
Clinical narrative: vaccine exposure during pregnancy; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of EXPOSURE DURING PREGNANCY (vaccine exposure during pregnancy) in a 30-year-old female patient (gravida 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on an unknown date and the estimated date of delivery was 11-Jul-2021. On 18-Mar-2021, the patient experienced EXPOSURE DURING PREGNANCY (vaccine exposure during pregnancy). At the time of the report, EXPOSURE DURING PREGNANCY (vaccine exposure during pregnancy) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication was provided.No treatment details was included.
Age: 87.0
Sex: F
Vaccine: COVID19
Symptoms: Muscle tightness, Musculoskeletal pain
Clinical narrative: Terrible tightness under left and right arm; Pain in muscles of Buttocks; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of MUSCLE TIGHTNESS (Terrible tightness under left and right arm) and MUSCULOSKELETAL PAIN (Pain in muscles of Buttocks) in an 87-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032M20A and 024M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced MUSCLE TIGHTNESS (Terrible tightness under left and right arm) and MUSCULOSKELETAL PAIN (Pain in muscles of Buttocks). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, MUSCLE TIGHTNESS (Terrible tightness under left and right arm) and MUSCULOSKELETAL PAIN (Pain in muscles of Buttocks) outcome was unknown.            For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessment.  Concomitant product included blood pressure medicine.   This case was linked to MOD-2021-065210 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 12-May-2021: Follow-up document was received on 12-MAY-2021. Reporter's address was added. It contains non significant information.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Diarrhoea, Dizziness, Dyspnoea, Fatigue
Clinical narrative: Dizzy; Difficulty breathing; Diarrhea; Headache; Tired; Fever; Chills; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizzy), DYSPNOEA (Difficulty breathing), DIARRHOEA (Diarrhea), HEADACHE (Headache) and FATIGUE (Tired) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Blood pressure and Cholesterol.    On 04-Mar-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, the patient experienced DIZZINESS (Dizzy), DYSPNOEA (Difficulty breathing), DIARRHOEA (Diarrhea), HEADACHE (Headache), FATIGUE (Tired), PYREXIA (Fever), CHILLS (Chills) and NAUSEA (Nausea). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 18-Mar-2021, DIZZINESS (Dizzy), DYSPNOEA (Difficulty breathing), DIARRHOEA (Diarrhea), HEADACHE (Headache), FATIGUE (Tired), PYREXIA (Fever), CHILLS (Chills) and NAUSEA (Nausea) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications reported were high blood pressure medicine and cholesterol medicine.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Nausea, Pyrexia
Clinical narrative: Dizzy; Difficulty breathing; Diarrhea; Headache; Tired; Fever; Chills; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizzy), DYSPNOEA (Difficulty breathing), DIARRHOEA (Diarrhea), HEADACHE (Headache) and FATIGUE (Tired) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Blood pressure and Cholesterol.    On 04-Mar-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, the patient experienced DIZZINESS (Dizzy), DYSPNOEA (Difficulty breathing), DIARRHOEA (Diarrhea), HEADACHE (Headache), FATIGUE (Tired), PYREXIA (Fever), CHILLS (Chills) and NAUSEA (Nausea). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 18-Mar-2021, DIZZINESS (Dizzy), DYSPNOEA (Difficulty breathing), DIARRHOEA (Diarrhea), HEADACHE (Headache), FATIGUE (Tired), PYREXIA (Fever), CHILLS (Chills) and NAUSEA (Nausea) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications reported were high blood pressure medicine and cholesterol medicine.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Ageusia, Dysgeusia
Clinical narrative: Metallic taste in her mouth; Also lost taste; This spontaneous case was reported by a consumer and describes the occurrence of DYSGEUSIA (Metallic taste in her mouth) and AGEUSIA (Also lost taste) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011M20A) for COVID-19 vaccination.     Concurrent medical conditions included Allergy to antibiotic (Biaxin).   On 15-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 15-Feb-2021, the patient experienced DYSGEUSIA (Metallic taste in her mouth) and AGEUSIA (Also lost taste). At the time of the report, DYSGEUSIA (Metallic taste in her mouth) had not resolved and AGEUSIA (Also lost taste) outcome was unknown.            The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was not applicable. Concomitant medications was not provided by the reporter. Treatment information was not provided.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Vaccination site pain
Clinical narrative: experienced pain with the first dose as well but not to this degree; Strong pain up to her shoulder and down to her fingers, pain is getting worse with time; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Strong pain up to her shoulder and down to her fingers, pain is getting worse with time) and VACCINATION SITE PAIN (experienced pain with the first dose as well but not to this degree) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 18-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Mar-2021, the patient experienced PAIN (Strong pain up to her shoulder and down to her fingers, pain is getting worse with time). On an unknown date, the patient experienced VACCINATION SITE PAIN (experienced pain with the first dose as well but not to this degree). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) for Pain, at an unspecified dose and frequency. At the time of the report, PAIN (Strong pain up to her shoulder and down to her fingers, pain is getting worse with time) had not resolved and VACCINATION SITE PAIN (experienced pain with the first dose as well but not to this degree) outcome was unknown.            The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was not applicable. Concomitant medications reported were Blood pressure medications for drug use for unknown indication.